Hikma Pharmaceuticals sell Barclays PLC
Start price
06.01.26
/
50%
€18.40
Target price
06.01.27
-
Performance (%)
-12.36%
Price
08:01
?
Summary
This prediction is currently active. The prediction for Hikma Pharmaceuticals shows a convincing performance of -12.36%. Dividends of €0.41 are taken into consideration when calculating the performance. This prediction currently runs until 06.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hikma Pharmaceuticals | 4.848% | 4.848% |
| iShares Core DAX® | 4,24 % | 2,86 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % |
| iShares S&P 500 | 3,53 % | 1,95 % |
Comments by Barclays_PLC for this prediction
In the thread Hikma Pharmaceuticals diskutieren
Hikma Pharmaceuticals (OTCMKTS:HKMPF) was downgraded by analysts at Barclays PLC to an "underweight" rating.
Ratings data for HKMPF provided by MarketBeat